A biomathematical model of SARS-CoV-2 in Syrian hamsters
Sibylle Schirm, Geraldine Nouailles, Holger Kirsten, Jakob Trimpert, Emanuel Wyler, Luiz Gustavo Teixeira Alves, Markus Landthaler, Peter Ahnert, Norbert Suttorp, Martin Witzenrath, Markus Scholz · 2024
Read A biomathematical model of SARS-CoV-2 in Syrian hamsters by Sibylle Schirm, Geraldine Nouailles, Holger Kirsten, Jakob Trimpert, Emanuel Wyler, Luiz Gustavo Teixeira Alves, Markus Landthaler, Peter Ahnert, Norbert Suttorp, Martin Witzenrath, Markus Scholz (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11655638.txt.
Description
Schirm and co-authors turn the course of COVID-19 in Syrian hamsters into a system of equations. Infected hamsters develop a moderate illness that mirrors key features of human disease, which makes them a standard test animal. The model follows the virus population, the lung lining cells it attacks, and the immune cells that respond, from killer T cells to antibody-making B cells. It also tracks the signaling molecules that rise and fall during infection.
The equations were fitted to lab data gathered on days two, three, five, and fourteen after infection, including single-cell profiles of lung tissue. The fitted model matched the data well. Its purpose is prediction: researchers can simulate how virus and immune cells would evolve under a candidate therapy before running the animal experiment. The authors aim in time to adapt the model to human infection.
Catalog record
| CREATOR | Sibylle Schirm, Geraldine Nouailles, Holger Kirsten, Jakob Trimpert, Emanuel Wyler, Luiz Gustavo Teixeira Alves, Markus Landthaler, Peter Ahnert, Norbert Suttorp, Martin Witzenrath, Markus Scholz |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 110 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |